Skip to content
Search

Latest Stories

Indian tycoon Mukesh Ambani loses Asia's richest crown to Jack Ma

INDIA'S business tycoon Mukesh Ambani has lost his crown as Asia's richest person to Jack Ma after the latest rout across global markets wiped almost $6 billion (£5bn) off his fortune, according to the Bloomberg Billionaires Index.

All told, the world's 500 richest people lost $238.5bn on Monday (9), according to Bloomberg, the biggest daily plunge since the index began tracking them in October 2016.


The sell-off erased $5.8bn from 62-year-old Ambani's net worth to leave him with a net worth of about $41.8bn.

He was overtaken by Chinese tycoon Jack Ma, the founder of Alibaba whose fortune had fallen about $1.1bn to $44.5bn.

The slump in crude oil prices raises questions about the plans by Ambani's Reliance Industries Limited (RIL) to cut debt as they hinge on selling a stake in its oil and petrochemicals unit to Saudi Aramco, Bloomberg reported.

RIL, the operator of world's biggest crude oil refining facility in the western Indian state of Gujarat slumped as much as 13.65 per cent, its biggest single-day fall in at least 10 years on Bombay Stock Exchange (BSE).

Equity and oil markets went into meltdown on what has been dubbed Black Monday as growing fears about the economic impact of COVID-19 were compounded by Saudi Arabia's decision to slash crude prices following a row with Russia over production cuts.

Crude prices tanked by a third in their worst drop since the 1991 Gulf War.

Meanwhile, Indian stocks on Monday recorded their worst single-day fall in more than four years, tracking global markets lower, as panic over the economic fallout of the coronavirus outbreak intensified and oil prices plummeted.

The NSE Nifty 50 index closed down 4.90 per cent at 10,451.45, its worst daily decline since August 2015.

The benchmark S&P BSE Sensex ended 5.17 per cent lower at 35,634.95.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less